[Abstract] The mucosal surfaces of the gastrointestinal, respiratory, reproductive, and urinary tracts, and the surface of the eye harbor a resident microflora that lives in symbiosis with their host and forms a complex ecosystem. The protection of the vulnerable epithelium is primarily achieved by mucins that form a gel-like structure adherent to the apical cell surface. This mucus layer constitutes a physical and chemical barrier between the microbial flora and the underlying epithelium. Mucus is critical to the maintenance of a homeostatic relationship between the microbiota and its host. Subtle deviations from this dynamic interaction may result in major implications for health. The protocol in this article describes the procedures to grow low mucus-producing HT29 and high mucus-producing HT29-MTX-E12 cells, maintain cells and use them for mucus quantification by ELISA. Additionally, it is described how to assess the amount of secreted adherent mucus. This system can be used to study the protective effect of mucus, e.g., against bacterial toxins, to test the effect of different culture conditions on mucus production or to analyze diffusion of molecules through the mucus layer. Since the ELISA used in this protocol is available for different species and mucus proteins, also other cell types can be used.
gastrointestinal tract (Tailford et al., 2015) . The secreted mucins form a gel-like structure adherent to the apical cell surface that constitutes a physical and chemical barrier between the luminal contents and the underlying epithelium (Allan, 2011) . Inflammasome activity controls the secretion of mucus in goblet cells and increased secretion of mucus is observed as the microbiota becomes more diverse (Jakobsson et al., 2015) . It is becoming apparent that mucus plays a crucial role in maintaining a homeostatic balance between microbiota and its host. Even small deviations from this dynamic interaction can have significant health effects, among which are colitis, colorectal cancer and susceptibility to infection (McGuckin et al., 2011; Hansson, 2012; Chen and Stappenbeck, 2014) .
In this protocol, we describe the culture of in vitro models producing different amounts of mucus depending on their culture condition (static vs. semi-wet with mechanical stimulation (Navabi et al., 2013 ). These models are based on the little to no mucus-producing HT29 cell line, a human colon adenocarcinoma cell line, and its high mucus-producing derivative HT29-MTX-E12 (E12). Furthermore, it is described how to quantify the mucus produced in the different models by ELISA. In addition, the mucolytic compound N-acetyl-L-cysteine (NAC) is used to remove adherent mucus in order to quantify the amount of secreted adherent mucus. A schematic overview of the workflow described in this protocol is provided in Figure 1 .
The method described in this protocol is suitable to study the protective effect of mucus against bacterial toxins (Reuter et al., 2018) , to test the effect of different culture conditions on mucus production (Navabi et al., 2013) or to analyze diffusion of molecules through the mucus layer. Since the ELISA used in this protocol is available for different species and mucus proteins, other cell types can also be used. The procedure of the mucus ELISA with subsequent data acquisition and analysis is explained in Procedure D and section "Data analysis" of this protocol.
Materials and Reagents

A. Growing and maintaining of HT29 and HT29-MTX-E12 (E12) cells
Note: Before you start, heat the cell culture medium to 37 °C. 2. Transfer the vial contents to a 15 ml centrifuge tube containing 9 ml warm cell culture medium and centrifuge at 300 x g for 5 min at room temperature with maximum acceleration/deceleration settings. Discard supernatant. Resuspend cells in 1 ml pre-warmed medium and transfer the cell suspension to a 175 cm 2 flask containing 25 ml pre-warmed medium. Place the flask in a humidified CO2 forced-air incubator at 37 °C.
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC. 2. To set up the models, add 275 µl of the cell suspension containing 7.5 x 10 4 HT29 or E12 cells to the apical side of the membrane and 1 ml medium to the basal compartment. Incubate the plates in the cell culture incubator overnight.
3. On the next day, the medium is changed and the culture condition semi-wet interface with mechanical stimulation (SWMS) is initiated to enhance mucus production.
a. To generate the static culture condition, replace the medium in the apical compartment with 275 µl and the basal compartment with 1 ml pre-warmed (37 °C) medium as described in
Step B4. Incubate the cells in a cell culture incubator for 15 days and maintain the media volumes during the medium change. C. Preparation of models for mucus quantification by ELISA 1. After 15 days, the models are ready and can be used for experiments. If quantification of secreted adherent mucus is required a subset of models should be treated as described in
Step C2, otherwise continue with Step C3. 2. The mucolytic agent N-acetyl-L-cysteine (NAC) is used to chemically remove adherent mucus.
Notes: a. Perceivable ideas for experiments could be to test the colonization efficacy of bacteria in presence and absence of an adherent mucus layer, or to test the diffusion of particles through the cell layer in presence and
NAC has a low order of toxicity and reduces the viscosity of mucus by irreversible reduction of disulfide bonds in mucoproteins.
a. For this purpose, remove the medium as described in Step B4.
b. Add 500 µl pre-warmed (37 °C) NAC working solution to the apical compartment and 1.5 ml pre-warmed (37 °C) medium to the basal compartment in order to balance the medium level in both compartments. Subsequently, place the prepared models on an orbital shaker for 1 h and 65 rpm in the cell culture incubator.
c. Wash both compartments once with PBS and continue with Step C3.
3. To detach cells, carefully aspirate the medium as described in Step B4 and carefully wash both compartments once with PBS by adding 500 µl to the apical and 1.5 ml to the basal compartment.
Remove PBS as described in
Step B4 and add pre-warmed (37 °C) trypsin-EDTA solution (500 µl apical, 1.5 ml basal) to each model. Incubate at 37 °C for 10-15 min in the cell culture incubator.
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC. D. ELISA and data acquisition 1. In the following step, the assay is performed according to the manufacturer's instructions.
Reconstitute the standard included in the kit and prepare a dilution series with 7 points.
Reconstitute all other components included in the kit according to the manufacturer's instructions. 
